Patient’s profiling for therapeutic management of inflammatory bowel disease: a tailored approach-Reference-Cited by-同舟云学术

Patient’s profiling for therapeutic management of inflammatory bowel disease: a tailored approach

Published:2020-05-28 Issue:9 Volume:14 Page:765-773
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

D’Amico Ferdinando¹²,Fiorino Gionata¹³,Furfaro Federica³,Allocca Mariangela¹³,Roda Giulia³^ORCID,Loy Laura³,Zilli Alessandra³,Solitano Virginia¹,Peyrin-Biroulet Laurent²,Danese Silvio¹³^ORCID

Affiliation:

1. Department of Biomedical Sciences, Humanitas University, Milan, Italy

2. Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France

3. IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, IRCCS, Milan, Italy

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2020.1772057

Reference110 articles.

1. Crohn's disease

2. Ulcerative colitis

3. ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

4. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

5. Positioning Therapies in Ulcerative Colitis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Patients with Ulcerative Colitis: A Real-World Retrospective Study;Biomedicines;2024-09-02

2. MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations;Digestive and Liver Disease;2024-09

3. TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis;Med;2024-05

4. Chronic illness trajectory-based nursing intervention improves the self-care abilities of patients with inflammatory bowel disease;American Journal of Translational Research;2024

5. Management and treatment optimization of patients with mild to moderate ulcerative colitis;Expert Review of Clinical Immunology;2023-12-07